Osteoporosis
Skeletal disorder
Ratings
0
Nobody has rated this yet. Be the first!
Influences rating
Influences rating
Subject of
13
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003.
Mice with alopecia, osteoporosis, and systemic amyloidosis due to mutation in Zdhhc13, a gene coding for palmitoyl acyltransferase
Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday
Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents
Fracture Prediction and the Definition of Osteoporosis in Children and Adolescents: The ISCD 2013 Pediatric Official Positions
Continuing bisphosphonate treatment for osteoporosis--for whom and for how long?
Alendronate for the Treatment of Osteoporosis in Men
Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays
Femoral and vertebral strength improvements in postmenopausal women with osteoporosis treated with denosumab.
Effects of Long-term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis
